Modern transfusion medicine is sophisticated hemotherapy. Cellular and humoral blood components can be relevant in virtually every disease, either as a primary determinant in pathophysiology or as a victim of collateral damage, e.g. during treatment with cytostatic drugs, or as crucial substrates in replacement and hemostasis-navigated hemotherapy. With its interdisciplinary approach modern hemotherapy is a paragon of translational research bridging the bench-to-bedside gap in biomedicine. The state-of-the-art contributions collected here aim to stimulate lively discussions - not only among blood center professionals but also with blood and vascular biologists, hematologists, immunologists, anesthesiologists, intensive care specialists, surgeons, cardiologists, nephrologists, rheumatologists, and pulmonary and infectious disease specialists.
189 - 198: Genotyping of Red Blood Cell, Granulocyte and Platelet Antigens: Current Applications in the German-Speaking Countries
-
Published:2008
-
Willy A. Flegel, Franz F. Wagner, 2008. "Genotyping of Red Blood Cell, Granulocyte and Platelet Antigens: Current Applications in the German-Speaking Countries", Progress and Challenges in Transfusion Medicine, Hemostasis, and Hemotherapy: State of the Art 200841st Congress of the German Society for Transfusion Medicine and Immunohematology, Düsseldorf, September 2008, R.E. Scharf
Download citation file: